ESC Premium Access

Survodutide, a glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist, improves cardiometabolic parameters in adults with obesity: analysis of a placebo-controlled, randomised phase 2 trial

Congress Presentation

About the speaker

Doctor Elena Startseva

(Germany)
0 follower

7 more presentations in this session

Improvement in cardiac function but not structure in adults born preterm following a prescribed moderate to high intensity exercise intervention: a randomized clinical trial

Speaker: Associate Professor A. Lewandowski (Oxford, GB)

Thumbnail

Effect of physical activity level on the association of LBBB, heart failure, and mortality

Speaker: Doctor Y. Bitton (Jerusalem, IL)

Thumbnail

Trajectories of physical activity among participants of six-month mobile app-based disease management program for cardiovascular risk: a group-based trajectory modelling approach

Speaker: Assistant Professor T. Adachi (Nagoya, JP)

Thumbnail

Regular supervised exercise training improves endothelial function, early atherosclerosis, arterial stiffness and endothelial progenitor cells in PCI patients.

Speaker: Professor J. Park (Seoul, KR)

Thumbnail

Changes in practice of exercise advice provision following the publication of ESC 2020 guidelines on sports cardiology and exercise at a central London inherited cardiac conditions outpatient service

Speaker: Doctor N. Jayaratne (London, GB)

Thumbnail

Access the full session

Exercise in heart disease

Speakers: Doctor E. Startseva, Associate Professor A. Lewandowski, Doctor Y. Bitton, Assistant Professor T. Adachi, Professor J. Park...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations